# Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study

> **NCT06323590** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 60 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06323590
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-02
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06323590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06323590, "Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06323590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
